NCT01217437 2021-07-23Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal TumorsNational Cancer Institute (NCI)Phase 2 Completed108 enrolled 14 charts